4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-048391
President, R&D sold 8,100 shares at $23.07 ($186,867)
- President, R&D acquired 8,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-09-01 | Option exercise | +8,100 | $4.12 | $33,372 | 97,759 | D |
| Bergstrom Donald A President, R&D | 2022-09-01 | Sale | −8,100 | $23.07 | $186,867 | 89,659 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-09-01 | Option exercise · Stock Option (Right to Buy) | −8,100 | 139,356 | D | ||
| Open-market sales · 8,100 sh · avg $23.07 · $186,867 | |||||||
Loading xslF345X03/doc4.xml…